ECR 2012 â Abstract Submission for Invest in the Youth Applicants ...
ECR 2012 â Abstract Submission for Invest in the Youth Applicants ...
ECR 2012 â Abstract Submission for Invest in the Youth Applicants ...
Transform your PDFs into Flipbooks and boost your revenue!
Leverage SEO-optimized Flipbooks, powerful backlinks, and multimedia content to professionally showcase your products and significantly increase your reach.
<strong>ECR</strong> <strong>2012</strong> – <strong>Abstract</strong> <strong>Submission</strong> <strong>for</strong> <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> <strong>Applicants</strong> INVEST IN THE YOUTH APPLICATION – GENERAL CONDITIONS The aim of <strong>the</strong> programme is to give young radiologists and radiographers <strong>in</strong> tra<strong>in</strong><strong>in</strong>g <strong>the</strong> chance to participate <strong>in</strong> <strong>the</strong> meet<strong>in</strong>g. Successful applicants will be offered free registration <strong>for</strong> <strong>ECR</strong> <strong>2012</strong>, five nights' hotel accommodation (<strong>for</strong> a fixed period: February 29 to March 5, <strong>2012</strong>) and free public transport <strong>for</strong> <strong>the</strong> duration of <strong>the</strong> congress. This offer is only available to young radiologists or radiographers who meet <strong>the</strong> follow<strong>in</strong>g criteria: • Radiologist <strong>in</strong> tra<strong>in</strong><strong>in</strong>g under 35 years OR radiographer under 30 years • Member of <strong>the</strong> ESR <strong>in</strong> 2011 • <strong>Submission</strong> of an abstract <strong>for</strong> ei<strong>the</strong>r EPOS TM or oral presentation between Jun 8 – Sept 12, 2011 ! The submitters of <strong>the</strong> 50 best-‐rated abstracts will be automatically accepted onto <strong>the</strong> programme. All o<strong>the</strong>r participants will be chosen accord<strong>in</strong>g to geopolitical spread. For more detailed <strong>in</strong><strong>for</strong>mation about <strong>the</strong> <strong>ECR</strong> <strong>2012</strong> – <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> programme, please visit <strong>the</strong> ESR website www.myESR.org ABSTRACT SUBMISSION GUIDELINES <strong>Submission</strong>s must be made onl<strong>in</strong>e at www.myESR.org/abstracts<strong>2012</strong>_iity <strong>Abstract</strong> submission required <strong>for</strong> <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong>-‐applications <strong>for</strong> <strong>ECR</strong> <strong>2012</strong> is possible from June 8 – September 12, 2011. GENERAL PROCEEDINGS <strong>Submission</strong>s are treated like all o<strong>the</strong>r abstract submissions <strong>for</strong> oral presentations or electronic exhibits. All submitted abstracts will be reviewed anonymously (double-‐bl<strong>in</strong>ded review process) by 3 <strong>in</strong>dependent referees. Notification of decisions will be emailed to <strong>the</strong> submitt<strong>in</strong>g author as soon as <strong>the</strong>y are available. Do NOT submit <strong>the</strong> same abstract nei<strong>the</strong>r to <strong>the</strong> regular EPOS TM abstract submission nor to <strong>the</strong> abstract submission system <strong>for</strong> oral presentations (submissions July-‐September 2011), as this will cause immediate rejection! DEADLINES FOR <strong>ECR</strong> <strong>2012</strong> – <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> applicants: <strong>Abstract</strong>s must be submitted by September 12, 2011 (24:00 CET) <strong>the</strong> latest. <strong>Submission</strong> after this date will not be possible to be taken <strong>in</strong>to consideration <strong>for</strong> <strong>the</strong> <strong>ECR</strong> <strong>2012</strong>-‐<strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> application process. Note: Regular abstract submission <strong>for</strong> posters to be shown at <strong>ECR</strong> <strong>2012</strong> (EPOS TM ) will be possible until December 31, 2011. <strong>ECR</strong> <strong>2012</strong> – <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> Applications – <strong>Abstract</strong> <strong>Submission</strong> Guidl<strong>in</strong>es, p.1 of 6
ABSTRACT TYPES Three abstract types are available: • • • Poster presentation – scientific exhibit* (EPOS): <strong>for</strong> standard scientific studies to be presented as an electronic poster with<strong>in</strong> <strong>the</strong> <strong>ECR</strong> <strong>2012</strong> electronic scientific exhibition (EPOS TM ). Poster presentation – educational exhibit* (EPOS): <strong>for</strong> educative description of a series of cases of a particular condition or perhaps a series of cases of a particular procedure (without hav<strong>in</strong>g carried out a study) to be presented as an electronic poster with<strong>in</strong> <strong>the</strong> <strong>ECR</strong> <strong>2012</strong> electronic scientific exhibition (EPOS TM ). Paper presentation (oral presentation): <strong>for</strong> standard scientific studies to be presented as an oral presentation with<strong>in</strong> a session dur<strong>in</strong>g <strong>ECR</strong> <strong>2012</strong>. *) In case of acceptance of a submitted poster abstract, authors must upload <strong>the</strong>ir digital material to <strong>the</strong> EPOS TM system by January 31, <strong>2012</strong>. All accepted posters are presented electronically <strong>in</strong> EPOS TM , (no paper pr<strong>in</strong>t outs). ABSTRACT FORMAT <strong>Abstract</strong>s should be submitted <strong>in</strong> a <strong>for</strong>mat ready <strong>for</strong> publication. Please check and avoid any typographic and grammatical errors. Note that <strong>the</strong> same study or content cannot be submitted <strong>for</strong> more than one abstract type. In order to start <strong>the</strong> submission process, a poster type must be chosen. Once chosen, <strong>the</strong> type cannot be changed. ! Note that case reports will not be accepted! The reviewers are <strong>in</strong>structed to filter <strong>the</strong>se out. We recommend submitt<strong>in</strong>g case reports to EURORAD (www.eurorad.org). AWARDS AND DISCUSSIONS Be<strong>for</strong>e <strong>the</strong> congress, <strong>the</strong> Scientific Exhibition Jury will evaluate uploaded posters and present Awards (Magna Cum Laude, Cum Laude, Certificate of Merit) to <strong>the</strong> best ones. In addition, authors of specially selected posters will be asked to present <strong>the</strong>ir work <strong>in</strong> person at <strong>ECR</strong> <strong>2012</strong>, <strong>in</strong> <strong>the</strong> EPOS, area dur<strong>in</strong>g moderated events. Those presented posters will receive an official diploma and prize. INSTRUCTIONS: HOW TO SUBMIT AN ABSTRACT GENERAL INFORMATION: It is recommended that authors prepare <strong>the</strong>ir abstracts <strong>in</strong> advance us<strong>in</strong>g any standard word process<strong>in</strong>g system, and <strong>the</strong>n ‘copy and paste’ <strong>the</strong> elements from <strong>the</strong> word process<strong>in</strong>g document <strong>in</strong>to <strong>the</strong> appropriate spaces <strong>in</strong> <strong>the</strong> submission system. Please do NOT <strong>in</strong>clude references, acknowledgements, graphics, tables or figures <strong>in</strong> your abstract body. Text should be submitted us<strong>in</strong>g standard Lat<strong>in</strong> characters. <strong>ECR</strong> <strong>2012</strong> – <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> Applications – <strong>Abstract</strong> <strong>Submission</strong> Guidl<strong>in</strong>es, p.2 of 6
SUBMISSION STEPS: 1. Choose a type <strong>for</strong> your abstract. Possible types are ‘Poster presentation -‐ scientific exhibit (EPOS)’ or ’Poster presentation -‐ educational exhibit (EPOS)’ or ‘Paper presentation (oral)’. 2. Enter <strong>the</strong> title <strong>for</strong> your abstract. Titles should all be lower case except <strong>for</strong> acronyms, proper names (e.g. Doppler, Crohn's, X-‐ray), <strong>the</strong> first letter and after colons. Do not use a full stop at <strong>the</strong> end of <strong>the</strong> title. Please spell out any Greek or scientific characters (e.g. beta) or use <strong>the</strong> Omega button (Ω) <strong>in</strong> <strong>the</strong> Editor and click on <strong>the</strong> character you want to <strong>in</strong>sert. 3. Select <strong>the</strong> appropriate keywords and / or topic from <strong>the</strong> respective lists. This selection determ<strong>in</strong>es how your abstract is reviewed and <strong>in</strong>dexed onl<strong>in</strong>e. You can chose up to 3 keywords per column; one keyword <strong>in</strong> each column is mandatory. In addition, abstracts <strong>for</strong> ‘Paper presentation (oral)’ must have one topic. 4. Add authors to your abstract. To avoid duplicate entries you have to search be<strong>for</strong>e you are allowed to create a new person entry. With<strong>in</strong> <strong>the</strong> author block you may change <strong>the</strong> roles Author and Presenter. One presenter must be selected. 5. Enter <strong>the</strong> abstract body. We recommend to enter <strong>the</strong> text by typ<strong>in</strong>g or copy<strong>in</strong>g and past<strong>in</strong>g pla<strong>in</strong> text from a prepared document. Keep strictly to <strong>the</strong> given structure. 6. Complete <strong>the</strong> required affirmations. 7. Check <strong>for</strong> correctness and completeness. When <strong>the</strong> abstract submission process is complete, a summary page is displayed and may be pr<strong>in</strong>ted <strong>for</strong> your own record. This page <strong>in</strong>cludes <strong>the</strong> abstract control number and full details of your submission. Please review this summary carefully to ensure that it is correct. If it is not, please edit accord<strong>in</strong>gly. 8. Submit your abstract by click<strong>in</strong>g ‘save and f<strong>in</strong>ish’. Please make sure that your abstract is properly structured and comprehensively checked <strong>for</strong> British English spell<strong>in</strong>g and grammar. ! Follow<strong>in</strong>g all <strong>in</strong>structions will improve <strong>the</strong> quality of your submission and thus <strong>in</strong>fluence its scores <strong>in</strong> a positive way. You can edit or delete your abstract onl<strong>in</strong>e at any time until <strong>the</strong> end of <strong>the</strong> submission month (submission phase). If you wish to withdraw your abstract after that date you must <strong>in</strong><strong>for</strong>m <strong>the</strong> ESR Office <strong>in</strong> writ<strong>in</strong>g by email. Detailed notifications of acceptance will be sent to you by email. <strong>ECR</strong> <strong>2012</strong> – <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> Applications – <strong>Abstract</strong> <strong>Submission</strong> Guidl<strong>in</strong>es, p.3 of 6
AFFIRMATIONS To f<strong>in</strong>alise abstract submission, each author must agree to <strong>the</strong> follow<strong>in</strong>g conditions: • that all authors are aware that <strong>the</strong>ir names appear on <strong>the</strong> abstract. • that if <strong>the</strong> abstract is accepted, <strong>the</strong> ESR (European Society of Radiology) will hold <strong>the</strong> copyright. • that if a poster abstract is accepted, <strong>the</strong> author must submit <strong>the</strong> digital poster material via EPOS, <strong>the</strong> <strong>ECR</strong>’s Electronic Presentation Onl<strong>in</strong>e System. The copyright of <strong>the</strong> digital poster material will be held by <strong>the</strong> ESR (European Society of Radiology). INSTRUCTIONS FOR ABSTRACT TYPES: POSTER PRESENTATION – SCIENTIFIC EXHIBITS and PAPER PRESENTATION (ORAL) <strong>Abstract</strong>s should <strong>in</strong>clude <strong>the</strong> follow<strong>in</strong>g elements: -‐ Title Please keep titles as long as necessary but as short as possible. Company and trade names, special symbols or characters are not allowed <strong>in</strong> <strong>the</strong> title. -‐ Author(s) A maximum of n<strong>in</strong>e authors can be listed. Only people that contributed to <strong>the</strong> work should be listed – gift or ghost authorship is strongly discouraged. Note that <strong>the</strong> system requires contact <strong>in</strong><strong>for</strong>mation (<strong>in</strong>cl. email address) <strong>for</strong> each author. -‐ Keywords A new list of keywords has been <strong>in</strong>troduced: four equally weighted keyword columns (Area of <strong>in</strong>terest, Technique, Procedure, Special focus) each conta<strong>in</strong><strong>in</strong>g a variety of terms relevant to radiology allows effective description and <strong>in</strong>dex<strong>in</strong>g of your work. A m<strong>in</strong>imum of one term is required and a maximum of three terms is allowed <strong>for</strong> each column. -‐ <strong>Abstract</strong> body The body of <strong>the</strong> abstract should summarise <strong>the</strong> subject <strong>in</strong> a maximum of 250 words, and should be structured as follows: • Purpose • Methods and Materials • Results • Conclusion Sample <strong>Abstract</strong> Body: Purpose: Partial volume averag<strong>in</strong>g effects complicate measurement of acoustic neuroma size with <strong>the</strong> error greatest <strong>in</strong> small tumors. A method of volume measurement that <strong>in</strong>corporates partial volume averag<strong>in</strong>g is <strong>in</strong>troduced. Methods and Materials: Post contrast T1 volume MR images were acquired from 48 patients. A computer generated phantom was created, mimick<strong>in</strong>g <strong>the</strong> partial volume and noise characteristics of acoustic neuromas. Manual volume segmentation is taken as <strong>the</strong> gold standard. Tumour diameter, perimeter length, elliptical and directly measured area were measured on <strong>the</strong> image demonstrat<strong>in</strong>g <strong>the</strong> largest tumour area. Three dimensional seed<strong>in</strong>g was per<strong>for</strong>med on <strong>the</strong> tumour volume as well as an algorithm developed <strong>for</strong> automated <strong>ECR</strong> <strong>2012</strong> – <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> Applications – <strong>Abstract</strong> <strong>Submission</strong> Guidl<strong>in</strong>es, p.4 of 6
estimation of tumour size us<strong>in</strong>g Bayesian classifiers. Results: Correlation with gold standard volume measure was greatest <strong>for</strong> <strong>the</strong> automated algorithm (95 % confidence <strong>in</strong>terval <strong>for</strong> R2 is 0.962 to 0.988), followed by measures of seed<strong>in</strong>g (0.773 to 0.923), ellipse (0.755 to 0.916), area (0.645 to 0.872), diameter (0.491 to 0.803), and perimeter (0.491 to 0.803). Phantom studies on partial volume regions show <strong>the</strong> accuracy of <strong>the</strong> partial volume measurement was 5 % (c.f. 13 % <strong>for</strong> repeated area measurements). Conclusion: A Bayesian statistical classification method can rapidly provide measures of tumour volume which are reproducible and offer better accuracy than current time consum<strong>in</strong>g gold standard techniques. This method should also <strong>in</strong>crease <strong>the</strong> accuracy of growth rate measurements <strong>for</strong> <strong>in</strong>tracanalicular acoustic neuromas. Important abstract elements: • Purpose should be clearly stated. • Precise description of methods and materials (patients), especially patient recruitment, analysis and statistics should be given. • Precise description of results with numbers and statistics should be <strong>in</strong>cluded. • Statistics should be appropriate. • Work-‐<strong>in</strong>-‐progress is only acceptable <strong>for</strong> extremely <strong>in</strong>novative or <strong>in</strong>terest<strong>in</strong>g approaches. • Coherence between stated purpose, methods and materials, results and conclusion is important. INSTRUCTIONS FOR ABSTRACT TYPE: POSTER PRESENTATION – EDUCATIONAL EXHIBITS A properly submitted abstract will <strong>in</strong>clude <strong>the</strong> follow<strong>in</strong>g elements: -‐ Title Please keep titles as long as necessary but as short as possible. Company and trade names, special symbols or characters are not allowed <strong>in</strong> <strong>the</strong> title. -‐ Author(s) A maximum of n<strong>in</strong>e authors can be listed. Only people that contributed to <strong>the</strong> work should be listed – gift or ghost authorship is strictly discouraged. Note that <strong>the</strong> system requires contact <strong>in</strong><strong>for</strong>mation (<strong>in</strong>cl. email address) <strong>for</strong> each author. -‐ Keywords A new list of keywords has been <strong>in</strong>troduced: four equally weighted keyword columns (Area of <strong>in</strong>terest, Technique, Procedure, Special focus) each conta<strong>in</strong><strong>in</strong>g a variety of terms relevant to radiology allows effective description and <strong>in</strong>dex<strong>in</strong>g of your work. A m<strong>in</strong>imum of one term is required and a maximum of three terms is allowed <strong>for</strong> each column. -‐ <strong>Abstract</strong> body The body of <strong>the</strong> abstract should summarise <strong>the</strong> subject <strong>in</strong> a maximum of 250 words, and should be structured as follows: • Learn<strong>in</strong>g Objectives • Background <strong>ECR</strong> <strong>2012</strong> – <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> Applications – <strong>Abstract</strong> <strong>Submission</strong> Guidl<strong>in</strong>es, p.5 of 6
• Imag<strong>in</strong>g F<strong>in</strong>d<strong>in</strong>gs or Procedure Details (use appropriate item) • Conclusion Sample <strong>Abstract</strong> Body: Learn<strong>in</strong>g Objectives: To illustrate <strong>the</strong> spectrum of percutaneous radiofrequency ablation of bone metastases. To outl<strong>in</strong>e <strong>the</strong> advantages and limits of <strong>the</strong> technique. To describe <strong>the</strong> best <strong>in</strong>dications and results of <strong>the</strong> method based on a series of 68 patients. Background: Pa<strong>in</strong>ful bone metastases commonly occur <strong>in</strong> advanced cancer patients. They are difficult to manage because of pa<strong>in</strong>, bone weaken<strong>in</strong>g, and reduction <strong>in</strong> mobility. In this exhibits we will describe <strong>the</strong> use of radiofrequency (RF) ablation <strong>in</strong> bone metastases with <strong>the</strong> most suitable <strong>in</strong>dications, <strong>the</strong> results, <strong>the</strong> advantages and <strong>the</strong> limits of this technique compared to <strong>the</strong> exist<strong>in</strong>g percutaneous <strong>in</strong>terventions. Between January 1999 and January 2002, 68 patients with bone metastases were treated <strong>in</strong> our department. The technique, <strong>in</strong>dications and contra<strong>in</strong>dications of radiofrequency ablation are described and illustrated. Procedure Details: A wet mono-‐ or bi-‐polar electrode was used <strong>for</strong> <strong>the</strong> ablation (Berchtold® Tuttl<strong>in</strong>gen, Germany). The procedure is per<strong>for</strong>med under general anaes<strong>the</strong>sia or regional block. The major <strong>in</strong>dication is palliative treatment of lytic bone metastases and pa<strong>in</strong> management. However, curative ablation is per<strong>for</strong>med <strong>in</strong> some special cases like bone metastases of thyroid cancer. In <strong>the</strong>se cases, <strong>the</strong> treatment beg<strong>in</strong>s with radiofrequency ablation with destruction of more than 90% of <strong>the</strong> lesion followed by 131-‐ iod<strong>in</strong>e <strong>the</strong>rapy to complete <strong>the</strong> ablation of residual tumour. Conclusion: Complete necrosis was observed <strong>in</strong> 85% of cases. Radio-‐frequency ablation of bone metastases was promis<strong>in</strong>g <strong>in</strong> pa<strong>in</strong> management with 78% of satisfactory results. CONTACT: General <strong>in</strong><strong>for</strong>mation about <strong>the</strong> submission can be obta<strong>in</strong>ed through <strong>the</strong> ESR Office: Neutorgasse 9, 1010 Vienna, Austria Phone: +43-‐1-‐533 40 64-‐0 Fax: +43-‐1-‐533 40 64-‐441 epos@myESR.org www.myESR.org If you have any questions about <strong>the</strong> <strong>ECR</strong> <strong>2012</strong> – <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> applications, please contact iity@myESR.org <strong>ECR</strong> <strong>2012</strong> – <strong>Invest</strong> <strong>in</strong> <strong>the</strong> <strong>Youth</strong> Applications – <strong>Abstract</strong> <strong>Submission</strong> Guidl<strong>in</strong>es, p.6 of 6